Strong investor interest eases fundraising at two Australian ventures
This article was originally published in Scrip
Executive Summary
Two bioventures in Australia have found no problems raising new money from investors, with both Bionomics and Benitec holding successful oversubscribed offers that they will use mainly to support their clinical pipelines.